Vice President - Portfolio Strategy & Pipeline

Novo Nordisk A/S; Plainsboro Township (NJ); On-site; USD 150,000 - 250,000; Full time

Job summary

This innovative firm is seeking a Vice President of Portfolio Strategy and Pipeline to lead the cardiometabolic portfolio. You will be responsible for establishing a comprehensive strategy that drives growth in diabetes, obesity, and cardiovascular diseases. Your role will involve collaborating with cross-functional teams to ensure effective commercialization of new assets and maximizing market share. The ideal candidate will have extensive experience in pharmaceutical marketing, a strong track record in strategic planning, and a passion for enhancing patient outcomes. Join a dynamic team focused on delivering exceptional patient experiences and driving business success through innovative strategies.

Qualifications

• 15+ years in pharmaceutical marketing with a focus on strategy and brand management.
• Proven leadership in cross-functional team collaboration and change management.

Responsibilities

• Lead cardiometabolic portfolio strategy for growth and market share.
• Develop integrated commercialization strategies for new therapeutic areas.

Skills

Strategic Brand Management

Market Access

Team Management

Cross-functional Collaboration

Presentation Skills

Commercial Planning

Financial Acumen

Innovative Market Shaping

Education

Bachelor's Degree

MBA or Equivalent

Job description

Facility: Commercial Marketing

Location:

Plainsboro, NJ, US

About the Department
Our Marketing Patients & Solutions group creates and delivers human-centered experiences, where innovation meets customer-centricity, driving the ultimate experience for our patients. Our focus extends beyond transactions to craft experiences as one fully integrated, aligned, and connected organization that puts empathy at the center, powered by insight and foresight.

We prioritize customer and patient experience through agile implementation and omnichannel orchestration, ensuring that every touchpoint is managed effectively for maximum engagement. Our team develops integrated, next-gen customer engagement strategies that enhance marketing and experience operations while operationalizing pharmacy solutions to improve patient services.

We employ an end-to-end approach to strategy, utilizing integrated actionable insights to inform our decision-making. This ensures our strategies are rooted in a deep understanding of customer needs and behaviors, enabling the identification of new opportunities. Our 'test and learn' mindset empowers us to iterate rapidly and refine our strategies based on real-world results.

We are building an intentional team culture comprised of diverse skill sets, united by the shared belief that reinvention and learning fuel continuous growth. Our focus on business planning, effective ways of working, and a project office environment enhances operational efficiency and drives success.

The Position

The Vice President, US Portfolio Strategy and Pipeline is responsible for and leads a team focused on the cardiometabolic portfolio strategy including developing clear, enterprise wide USO perspective on all cardiometabolic pipeline assets, early product management, opportunity and drug identification, early commercialization strategy, pipeline strategy and product transition.

Establish the US portfolio strategy to drive the future growth of the Novo Nordisk cardiometabolic portfolio which includes diabetes, obesity, cardiovascular diseases, and future therapeutic areas/disease states. Steer the global cardiometabolic portfolio strategy to implement an integrated long-term plan reflecting the needs of the US market to enhance patient therapy outcomes, maximize portfolio revenue, grow market share, and meet business profitability goals. Partner with Rare Disease to ensure clear USO prioritization and trade-offs as it relates to cross disease area decision making.

Facilitate the development of a customer centric, enterprise-wide strategy for new therapy areas, including market development and go-to-market considerations, pipeline products development focusing on a time horizon of 18 months from commercialization and partner with Global on BD&L opportunities relevant to the US business.

Support the transition to internal stakeholders to ensure operationalization of the commercialization of new assets and maximization of US entry in those new therapeutic areas.

Relationships

Reports to SVP, Marketing & Patient Solutions. The VP, Portfolio Strategy & Pipeline is a member of US Marketing & Patient Solutions leadership team, and represents the portfolio plans in management discussions. Interacts and aligns CMR, Business Development, Market Access, Finance, Enterprise Strategy and relevant global Commercial and Development teams to develop clear US perspectives. Represents the US portfolio position to facilitate decision making on US and global BD&L committees.

Essential Functions

• Integrated Portfolio Strategy: Recommend strategic trade-offs on resource allocation and budgeting across portfolio.
• Own commercial input for Business Development and Licensing committees.
• Pipeline Strategy: Develop, communicate, and update the Comprehensive US enterprise – wide perspective on pipeline assets inclusive of trade-off consideration. Effectively analyze and assess new disease areas. Determine and own early product resource allocation decisions and investments. Provide pipeline strategy and pre-launch access inputs in collaboration with US cross-functional. Conduct annual plans for early products and provide portfolio and pipeline prioritization recommendations.
• Early Product Management: Establish the early commercialization strategy for new assets. Lead early product component of lifecycle management strategy. Proactively align with relevant functional partners.
• Product Transition: Make recommendations regarding all asset transitions and the timeline.
• BD&L (Opportunity): Identify critical opportunities to meet cardiometabolic pipeline goals and partner with business development to ensure gaps, strategies and opportunities are well understood. Determine areas of opportunity to better meet customer and patient needs.
• BD&L (Commercialization Strategy): Develop the integrated commercialization strategy for acquired assets including the situation scan, critical success factors, market access considerations, product positioning, and recommended resourcing.
• Innovative Launch Excellence: Spearhead the strategic planning and execution of product launches, emphasizing market readiness and optimized commercial success. Utilize customer insights and market intelligence to adapt and refine strategies dynamically during the launch process, ensuring alignment with market needs. Implement structured launch excellence frameworks, including Pre-Launch and Post-Launch performance assessments to gather learnings and drive continuous improvement. Foster cross-functional collaboration and engagement to create a unified launch approach, ensuring all teams are aligned on objectives, messaging, and tactical execution.
• Holistic Feedback Mechanism: Provide comprehensive and constructive feedback to the development organization, global BD, and the Executive Team regarding market needs and requirements to enhance the likelihood of successful future product launches in the US. Contribute insights on competitive landscape, customer preferences, and regulatory considerations to inform product development and positioning strategies.

Physical Requirements

Development of People

• Setting and communicating clear individualized role expectations for each report based on position, skills, talents, and objectives.
• Ensure that reporting personnel have strengths-based individual development plans (IDP), with annual goals and measurements that are consistent with the priorities of the business, and that regular and consistent reviews are held so that their work is focused on those priorities, and they understand their level of accountability for results and the measurement process.
• Ensure that the IDP forms include completed learning and aspiration plans and are in place for all reporting personnel to enable the achievement of goals and capability to assume increased levels of responsibility.

Qualifications

• 15+ years experience, including a demonstrated history within multiple specialized marketing areas in the pharmaceutical industry, such as launch readiness, strategic brand management, etc. with a progressive increase in responsibility and scope.
• Extensive experience with corporate business strategy development and planning, marketing and market development, market access, consulting, or commercial operations desired.
• 5+ years experience managing a team.
• Demonstrated collaboration skills in leading cross-functional teams required.
• Embodies leadership behaviors, including authenticity, servant leadership, will, empathy, decisiveness, and driving focus and simplicity.
• Demonstrated experience leading organizational change and establishing high performance culture.
• Excellent presentation/communications skills required.
• Proven track record of innovative market shaping accomplishments/high impact results (based on metrics/ROI).
• Experience with local and global operations within life sciences preferred.
• Demonstrated success in commercial planning, launching, growing and managing products through their life cycle.
• Solid understanding of the marketplace and competition, preferably within diabetes.
• Strategic Planning, Execution and follow-through skills required.
• Ability to impact and influence and interact with senior business leaders and partners.
• Experience with management of outside agencies.
• Deep expertise in financial and business acumen to inform strategic choices and tradeoffs at the portfolio level (e.g., product/customer prioritization, business development priorities).
• Experience with portfolio/mega-brand strategy (across multiple indications).
• Ability to influence and inspire tenured individuals and teams.